Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NY-ESO-1 TCR/IL-15 NK |
Trade Name | |
Synonyms | |
Drug Descriptions |
Limited information is currently available on NY-ESO-1 TCR/IL-15 NK, a putative natural killer cell therapy targeting NY-ESO-1 (Oct 2023). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cyclophosphamide + Fludarabine + NY-ESO-1 TCR/IL-15 NK | Cyclophosphamide Fludarabine NY-ESO-1 TCR/IL-15 NK | 0 | 2 |
NY-ESO-1 TCR/IL-15 NK | NY-ESO-1 TCR/IL-15 NK | 0 | 0 |